» Articles » PMID: 36745545

The Use of Representative Community Samples to Assess SARS-CoV-2 Lineage Competition: Alpha Outcompetes Beta and Wild-type in England from January to March 2021

Abstract

Genomic surveillance for SARS-CoV-2 lineages informs our understanding of possible future changes in transmissibility and vaccine efficacy and will be a high priority for public health for the foreseeable future. However, small changes in the frequency of one lineage over another are often difficult to interpret because surveillance samples are obtained using a variety of methods all of which are known to contain biases. As a case study, using an approach which is largely free of biases, we here describe lineage dynamics and phylogenetic relationships of the Alpha and Beta variant in England during the first 3 months of 2021 using sequences obtained from a random community sample who provided a throat and nose swab for rt-PCR as part of the REal-time Assessment of Community Transmission-1 (REACT-1) study. Overall, diversity decreased during the first quarter of 2021, with the Alpha variant (first identified in Kent) becoming predominant, driven by a reproduction number 0.3 higher than for the prior wild-type. During January, positive samples were more likely to be Alpha in those aged 18 to 54 years old. Although individuals infected with the Alpha variant were no more likely to report one or more classic COVID-19 symptoms compared to those infected with wild-type, they were more likely to be antibody-positive 6 weeks after infection. Further, viral load was higher in those infected with the Alpha variant as measured by cycle threshold (Ct) values. The presence of infections with non-imported Beta variant (first identified in South Africa) during January, but not during February or March, suggests initial establishment in the community followed by fade-out. However, this occurred during a period of stringent social distancing. These results highlight how sequence data from representative community surveys such as REACT-1 can augment routine genomic surveillance during periods of lineage diversity.

Citing Articles

Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.

Eales O, Haw D, Wang H, Atchison C, Ashby D, Cooke G PLoS Biol. 2023; 21(5):e3002118.

PMID: 37228015 PMC: 10212114. DOI: 10.1371/journal.pbio.3002118.


Genomics-informed outbreak investigations of SARS-CoV-2 using civet.

OToole A, Hill V, Jackson B, Dewar R, Sahadeo N, Colquhoun R PLOS Glob Public Health. 2023; 2(12):e0000704.

PMID: 36962792 PMC: 10021969. DOI: 10.1371/journal.pgph.0000704.


SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2.

Eales O, Page A, de Oliveira Martins L, Wang H, Bodinier B, Haw D BMC Infect Dis. 2022; 22(1):647.

PMID: 35896970 PMC: 9326417. DOI: 10.1186/s12879-022-07628-4.


Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number.

Eales O, Ainslie K, Walters C, Wang H, Atchison C, Ashby D Epidemics. 2022; 40:100604.

PMID: 35780515 PMC: 9220254. DOI: 10.1016/j.epidem.2022.100604.


Development of synthetic antigen vaccines for COVID-19.

Invencao M, Melo A, Macedo L, da Costa Neves T, de Melo C, Cordeiro M Hum Vaccin Immunother. 2021; 17(11):3855-3870.

PMID: 34613880 PMC: 8506811. DOI: 10.1080/21645515.2021.1974288.

References
1.
Riley S, Atchison C, Ashby D, Donnelly C, Barclay W, Cooke G . REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: Study protocol. Wellcome Open Res. 2021; 5:200. PMC: 8095190. DOI: 10.12688/wellcomeopenres.16228.2. View

2.
Elliott P, Bodinier B, Eales O, Wang H, Haw D, Elliott J . Rapid increase in Omicron infections in England during December 2021: REACT-1 study. Science. 2022; 375(6587):1406-1411. PMC: 8939772. DOI: 10.1126/science.abn8347. View

3.
Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J . Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021; 592(7854):438-443. DOI: 10.1038/s41586-021-03402-9. View

4.
Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z . Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020; 20(8):911-919. PMC: 7185944. DOI: 10.1016/S1473-3099(20)30287-5. View

5.
Challen R, Brooks-Pollock E, Read J, Dyson L, Tsaneva-Atanasova K, Danon L . Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMJ. 2021; 372:n579. PMC: 7941603. DOI: 10.1136/bmj.n579. View